ADC Therapeutics S.A. (ADCT) Social Stream
ADC Therapeutics SA (ADCT) Price Targets From Analysts
Use the tables below to see what analysts covering ADC Therapeutics SA think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Over the past 115 days, ADCT's average upside potential has been 141.37%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ADCT Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 120 days, ADCT's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ADCT as an investment opportunity.
- ADC Therapeutics SA's upside potential (average analyst target price relative to current price) is higher than 257.62% of all US stocks.
- ADCT has a lower variance in analysts' estimates than -126.45% of all US stocks.
- ADC Therapeutics SA's average analyst price target is greater than 186.31% of Pharmaceutical Products stocks.
- ADC Therapeutics SA's number of analysts covering the stock is higher than 180.06% of Pharmaceutical Products stocks.
Make investment decisions regarding ADCT using the data that counts. Try POWR Ratings for free.